How much does the genuine Adagraxibu cost?

Adagrasib is an oral drug that belongs to a class of targeted drugs called KRAS G12C inhibitors. It is designed to treat certain types of cancer, primarily those with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutations. KRAS G12C mutation is a common cancer-related mutation, especially in NSCLC.

Adagorasib has not yet been introduced in China, so domestic patients cannot purchase it directly and can only turn to foreign markets. However, the price of original drugs in the United States is as high as 180,000 yuan, which is undoubtedly a heavy burden for ordinary families.

The good news is that generic drugs of adagrasibu have recently been launched abroad, represented by products from Lucius Pharmaceuticals in Laos, which sell for only four to five thousand yuan per box, which is significantly lower than the price of the original drug. What’s even more gratifying is that this generic drug has basically the same ingredients as the original drug, providing patients with a more economical choice.

Adagrasib inhibits the KRAS G12C mutated protein and interferes with its activity in cancer cells, thus blocking the proliferation and growth of cancer cells. Compared with traditional chemotherapy drugs, adagrasib has a more precise mechanism of action, reducing the adverse effects on normal cells, thus reducing the incidence of toxic side effects. This makes it easier for patients to tolerate the treatment and improves its safety and effectiveness.

As a targeted drug, adagrasib represents innovation and progress in the field of cancer treatment. By targeting therapeutic strategies against specific mutations, it provides new treatment options for patients for whom traditional treatments are ineffective or unsuitable. With further research and clinical trials, adagrasib is expected to become one of the important drugs for the treatment of tumors, providing patients with better survival and quality of life.